943 / 1631
P=0.012
18
15
45
40
0
10
20
30
40
50
OR
CR
P=0.008
% Patients
Response at EOT
(IRC)*
33
20
70
58
0
20
40
60
80
BOR
CR
% Patients
Best Overall Response (INV)
*Primary
endpoint
Note: EOT IRC and INV assessments were highly concordant (>90%)
BOR, best overall response; CR, complete response; INV, investigator; IRC, independent review committee; EOT, end of treatment
DLBCL: Significantly Higher PET-CR with Pola-BR
Pola-BR
BR
91